A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells

被引:434
作者
Gautier, G
Humbert, M
Deauvieau, F
Scuiller, M
Hiscott, J
Bates, EEM
Trinchieri, G
Caux, C [1 ]
Garrone, P
机构
[1] Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France
[2] McGill Univ, Dept Microbiol, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, Dept Immunobiol Med, Montreal, PQ H3T 1E2, Canada
关键词
D O I
10.1084/jem.20041964
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DC) produce interleukin-12 (IL-12) in response to Toll-like receptor (TLR) activation. Two major TLR signaling pathways participate in the response to pathogens: the nuclear factor-kappa B (NF-kappa B)-dependent pathway leading to inflammatory cytokine secretion including IL-12 and the interferon (IFN)-dependent pathway inducing type I IFN and IFN-regulated genes. Here we show that the two pathways cooperate and are likely both necessary for inducing an optimal response to pathogens. R-848/Resiquimod (TLR7 ligand in the mouse and TLR7/8 ligand in human) synergized with poly(I:C) (TLR3 ligand) or lipopolysaccharide (LPS; TLR4 ligand) in inducing high levels of bioactive IL-12p70 secretion and IFN-beta mRNA accumulation by mouse bone marrow-derived DC (BM-DC). Strikingly, IL-12p70 but not IL-12p40 secretion was strongly reduced in BM-DC from STAT1(-/-) and IFNAR(-/-) mice. STAT1 tyrosine-phosphorylation, IL-12p35, and IFN-beta mRNA accumulation were strongly inhibited in IFNAR(-/-) BM-DC activated with the TLR ligand combinations. Similar observation were obtained in human TLR8-expressing monocyte-derived DC (moDC) using neutralizing anti-IFNAR2 antibodies, although results also pointed to a possible involvement of IFN-lambda 1 (also known as IL-29). This suggests that TLR engagement on DC induces endogenous IFNs that further synergize with the NF-kappa B pathway for optimal IL-12p70 secretion. Moreover, analysis of interferon regulatory factors (IRF) regulation in moDC suggests a role for IRF7/8 in mediating IRF3-independent type I IFN and possibly IL-12p35 synthesis in response to TLR7/8.
引用
收藏
页码:1435 / 1446
页数:12
相关论文
共 80 条
[71]   How cells respond to interferons [J].
Stark, GR ;
Kerr, IM ;
Williams, BRG ;
Silverman, RH ;
Schreiber, RD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :227-264
[72]   Toll-like receptors [J].
Takeda, K ;
Kaisho, T ;
Akira, S .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :335-376
[73]   IRF family of transcription factors as regulators of host defense [J].
Taniguchi, T ;
Ogasawara, K ;
Takaoka, A ;
Tanaka, N .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :623-655
[74]   TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages [J].
Toshchakov, V ;
Jones, BW ;
Perera, PY ;
Thomas, K ;
Cody, MJ ;
Zhang, SL ;
Williams, BRG ;
Major, J ;
Hamilton, TA ;
Fenton, MJ ;
Vogel, SN .
NATURE IMMUNOLOGY, 2002, 3 (04) :392-398
[75]   Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4 [J].
Triantafilou, K ;
Triantafilou, M .
JOURNAL OF VIROLOGY, 2004, 78 (20) :11313-11320
[76]   Interleukin-12 and the regulation of innate resistance and adaptive immunity [J].
Trinchieri, G .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (02) :133-146
[77]  
Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466
[78]   Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod [J].
Wagner, TL ;
Ahonen, CL ;
Couture, AM ;
Gibson, SJ ;
Miller, RL ;
Smith, RM ;
Reiter, MJ ;
Vasilakos, JP ;
Tomai, MA .
CELLULAR IMMUNOLOGY, 1999, 191 (01) :10-19
[79]   Identification of a TLR4- and TRIF-dependent activation program of dendritic cells [J].
Weighardt, H ;
Jusek, G ;
Mages, J ;
Lang, R ;
Hoebe, K ;
Beutler, B ;
Holzmann, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :558-564
[80]   Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity [J].
Whitmore, MM ;
DeVeer, MJ ;
Edling, A ;
Oates, RK ;
Simons, B ;
Lindner, D ;
Williams, BRG .
CANCER RESEARCH, 2004, 64 (16) :5850-5860